Bioxytran (BIXT) Common Equity (2010 - 2026)
Bioxytran's Common Equity came in at -$4.94 million for Q2 2026, compared with -$2.64 million a year earlier.
Powered by 
Analysis
Bioxytran (BIXT) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Bioxytran's Common Equity was -$2.59 million.
- Going back by year, Common Equity was -$1.79 million in FY2024, -$3.1 million in FY2023, -$3.3 million in FY2022 and -$3.16 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Common Equity in data going back to Q4 2010.
- Business Quant data shows BIXT's Common Equity at -$4.39 million (Q1 2026), -$2.59 million (Q4 2025) and -$2.9 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | -4.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.94 Mn |
| Mar 31, 2026 | -4.39 Mn |
| Dec 31, 2025 | -2.59 Mn |
| Sep 30, 2025 | -2.90 Mn |
| Jun 30, 2025 | -2.64 Mn |
| Mar 31, 2025 | -2.71 Mn |
| Dec 31, 2024 | -1.79 Mn |
| Sep 30, 2024 | -1.08 Mn |
| Jun 30, 2024 | -1.10 Mn |
| Mar 31, 2024 | -990,424.00 |
| Dec 31, 2023 | -3.10 Mn |
| Sep 30, 2023 | -2.14 Mn |
| Jun 30, 2023 | -2.66 Mn |
| Mar 31, 2023 | -4.06 Mn |
| Dec 31, 2022 | -3.30 Mn |
| Sep 30, 2022 | -2.55 Mn |
| Jun 30, 2022 | -4.76 Mn |
| Mar 31, 2022 | -4.08 Mn |
| Dec 31, 2021 | -3.16 Mn |
| Sep 30, 2021 | -1.92 Mn |
API Access
Bioxytran Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();